| EPA0107 | SARS-CoV-2 infection and Spike protein exposure alter iPSC-derived human brain organoid homeostasis | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0106 | Characterization of SARS-CoV-2 diagnostic and subgenomic RNA viral dynamics and seroconversion via Bayesian hierarchical modeling | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0105 | High levels of soluble endothelial cell protein C receptor in plasma of individuals with Long-COVID proves the role of endothelial dysfunction in the persistence of COVID-19 | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0104 | Comparable cellular response between people living with HIV and healthy donors against SARS-CoV-2 six months after receiving two doses of currently approved COVID-19 vaccines | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0103 | Humoral immune responses to ancestral SARS-CoV-2 wild type and variant strains following COVID-19 vaccination in people with HIV | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0102 | Persistent immune alterations in individuals with Long-COVID during a 6-months period | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0101 | UV-C radiation induces disulphide bond cleavage in SARS-CoV-2 spike protein reducing its binding to ACE2 on host cells | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0100 | Serum level of Macrophage migration Inhibitory Factor (MIF) is elevated during acute COVID-19 but not associated with severity, in donors from a biobank from Buenos Aires, Argentina | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0099 | No impact of HIV status on COVID-19 vaccine responses in Botswana | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPA0098 | Heterogeneity in neutralizing antibody responses following COVID-19 vaccination in Japanese people living with HIV | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |